Unlike in breast cancer, where HER2 overexpression is well-established and successfully targeted by therapies like trastuzumab, only rare individual cases of melanoma exhibit HER2 alterations that lead to HER2 overexpression. The gene discussed is ERBB2; the disease is breast carcinoma.